Update on the management of cutaneous lupus erythematosus.
This paper reviews the latest treatments for cutaneous lupus erythematosus. It focuses on evidence-based guidance for the management of cutaneous lupus erythematosus, with identification of the strength of evidence available at this time. In addition, I have briefly reviewed the epidemiological aspects, diagnosis and evaluation of patients with cutaneous lupus erythematosus. This review reflects data available from the Cochrane Library, Medline, literature searches, and the experience of the author managing patients with cutaneous lupus erythematosus for over 25 years.
Callen
J P
JP
Division of Dermatology, University of Louisville School of Medicine, Louisville, KY 40292, USA. fefca@aol.com
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000175:diagnosis / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D003879:Dermatologic Agents; D013792:Thalidomide